EP Patent

EP3315494A1 — Amorphous form of lesinurad and processes for its preparation

Assigned to Quimica Sintetica SA · Expires 2018-05-02 · 8y expired

What this patent protects

It is described the amorphous form of the compound lesinurad, having the formula reported below: Also described are several processes for the preparation of said amorphous form.

USPTO Abstract

It is described the amorphous form of the compound lesinurad, having the formula reported below: Also described are several processes for the preparation of said amorphous form.

Drugs covered by this patent

Patent Metadata

Patent number
EP3315494A1
Jurisdiction
EP
Classification
—
Expires
2018-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Quimica Sintetica SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.